FDA applicant

American Bioclinical, Inc.

Portland, OR4 decisions1985–19850 recalls

FDA records 4 decisions for American Bioclinical, Inc. (Portland, OR) in 1985: 4 510(k) clearances. Most are in product codes CGR (Radioimmunoassay, Cortisol) and CFT (Radioimmunoassay, Prolactin (Lactogen)). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided American Bioclinical, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for American Bioclinical, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — American Bioclinical, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like American Bioclinical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

American Bioclinical, Inc.

Which product codes does it file in?

What has FDA decided for it lately?